1. Home
  2. TZOO vs CLNN Comparison

TZOO vs CLNN Comparison

Compare TZOO & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travelzoo

TZOO

Travelzoo

N/A

Current Price

$6.35

Market Cap

60.3M

ML Signal

N/A

Logo Clene Inc.

CLNN

Clene Inc.

N/A

Current Price

$5.46

Market Cap

48.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TZOO
CLNN
Founded
1998
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.3M
48.4M
IPO Year
2003
N/A

Fundamental Metrics

Financial Performance
Metric
TZOO
CLNN
Price
$6.35
$5.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$16.00
$32.67
AVG Volume (30 Days)
211.8K
60.3K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
27.71
N/A
EPS
0.39
N/A
Revenue
N/A
N/A
Revenue This Year
$10.93
N/A
Revenue Next Year
$9.25
$82.05
P/E Ratio
$17.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.72
$2.28
52 Week High
$16.56
$13.50

Technical Indicators

Market Signals
Indicator
TZOO
CLNN
Relative Strength Index (RSI) 53.16 57.15
Support Level $4.72 $3.54
Resistance Level $7.45 $5.71
Average True Range (ATR) 0.44 0.46
MACD 0.10 0.11
Stochastic Oscillator 61.36 87.89

Price Performance

Historical Comparison
TZOO
CLNN

About TZOO Travelzoo

Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment, which is the key revenue driver, consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; and New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: